Stock Based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended										12 Months Ended
	Aug. 10, 2020	May 25, 2020	Oct. 31, 2020	Jun. 30, 2020	Apr. 30, 2020	Jul. 31, 2019	Apr. 30, 2019	Jan. 31, 2019	Dec. 31, 2018	Aug. 31, 2018	Apr. 30, 2017	Mar. 31, 2017	Dec. 31, 2020	Dec. 31, 2019
Stock Based Compensation (Textual)
Stock-based compensation expense													$ 0	$ 48
Number of issuance of common stock													5,363,870
Common stock shares issued													7,232,836	2,085,900
Stock option compensation expense													$ 560	$ 540
Unrecognized compensation cost													$ 737
Weighted-average period													2 years 9 months
Consultant3 [Member]
Stock Based Compensation (Textual)
Number of issuance of common stock														10,417
Consulting agreement, description											The Company engaged a consultant (“Consultant3”) to provide services to the Company with respect to financing and strategic advisory for a period of two years. For such consulting services, the Company agreed to pay a monthly retainer and agreed to issue to Consultant3 3,334 shares of the Company common stock and 2,084 shares each quarter thereafter.
Consultant10 [Member]
Stock Based Compensation (Textual)
Number of options to purchase common stock										3,334
Exercise price										$ 15.00
Stock-based equity -awards													$ 17	$ 22
Consultant11 [Member]
Stock Based Compensation (Textual)
Number of options to purchase common stock									3,334
Exercise price									$ 11.325
Stock-based equity -awards													0	29
Consultant12 [Member]
Stock Based Compensation (Textual)
Warrants to purchase								3,334
Stock-based equity -awards													0	42
Warrant exercisable price per share								$ 15.00
Consultant12 One [Member]
Stock Based Compensation (Textual)
Warrants to purchase								6,667
Consultant13 [Member]
Stock Based Compensation (Textual)
Number of options to purchase common stock							2,667
Stock-based equity -awards													3	8
Stock option expire term							2 years
Options exercisable price per share							$ 15.00
Consultant14 [Member]
Stock Based Compensation (Textual)
Number of options to purchase common stock						2,667
Stock-based equity -awards													8	$ 3
Stock option expire term						4 years
Options exercisable price per share						$ 15.00
Consultant14 One [Member]
Stock Based Compensation (Textual)
Number of options to purchase common stock						22,233
Stock option expire term						5 years
Options exercisable price per share						$ 1.08
Consultant15 [Member]
Stock Based Compensation (Textual)
Number of options to purchase common stock				7,500
Stock-based equity -awards													4
Options exercisable price per share				$ 1.3
Consultant16 [Member]
Stock Based Compensation (Textual)
Number of options to purchase common stock					6,000
Stock-based equity -awards													1
Stock option expire term					18 months
Options exercisable price per share					$ 2.00
Consultant17 [Member]
Stock Based Compensation (Textual)
Number of options to purchase common stock			15,000
Stock-based equity -awards													$ 3
Stock option expire term			4 years
Options exercisable price per share			$ 1.10
Employee Stock Option [Member]
Stock Based Compensation (Textual)
Number of issuance of common stock												200,000
Exercise price of outstanding options, description	The Company's shareholders approved an increase in the shares available for issuance under the 2017 Employee Plan from 200,000 to 1,450,000 shares. As a result and pursuant to approval of the Company's compensation committee that was contingent on the foregoing shareholder approval, the following occurred on August 10, 2020: (i) the number of shares available for issuance under the Company's 2017 Consultant Incentive Plan was reduced from 466,667 to 216,667 shares: (ii) the Company granted to the Company's Chief Executive Officer (A) five-year options to purchase up to 160,000 ordinary shares at an exercise price of $1.04 per share. One quarter of such options vested on November 26, 2020, one quarter vest on May 26, 2021, one quarter vest on November 26, 2021 and one quarter vest on May 26, 2022, and (B) 80,000 performance-based restricted stock units, each representing the right to receive one share of common stock, which vest (x) upon the Company generating revenue of at least $50,000 in the Russian Federation during the year ended 2020, or (y) upon the Company generating revenue of at least $500,000 in the Russian Federation during the year ending 2021; (iii) the Company granted five-year options to purchase up to 130,000 ordinary shares to the Company's Chief Financial Officer at an exercise price of $1.04 per share. One quarter of such options vested on November 26, 2020, one quarter vest on May 26, 2021, one quarter vest on November 26, 2021 and one quarter vest on May 26, 2022; (iv) the Company granted five-year options to purchase up to 130,000 ordinary shares to the Company's Chief Operating Officer and Chief Product Officer at an exercise price of $1.04 per share. One quarter of such options vested on November 26, 2020, one quarter vest on May 26, 2021, one quarter vest on November 26, 2021 and one quarter vest on May 26, 2022; (v) the Company granted five-year options to purchase up to 325,893 ordinary shares to other employees of the Company at an exercise price of $1.04 per share. One quarter of such options vested on November 26, 2020, one quarter vest on May 26, 2021, one quarter vest on November 26, 2021 and one quarter vest on May 26, 2022; and (vi) the Company granted five-year options to purchase up to 30,000 ordinary shares to each of the Company's non-employee board members at an exercise price of $1.04 per share. These options vested on November 26, 2020.	The compensation committee of the Board of Directors of the Company reduced the exercise price of outstanding options of employees and directors of the Company for the purchase of an aggregate of 140,237 shares of common stock of the Company (with exercise prices ranging between $18.15 and $9.15) to $1.04 per share, which was the closing price for the Company’s common stock on May 22, 2020, and extended the term of the foregoing options for an additional one year from the original date of expiration. The incremental compensation cost resulting from the repricing was $53, and the expenses during the year ended December 31, 2020 was $50.
Stock option granted													861,999	103,601
Employee Stock Option [Member] | Research and Development Expenses [Member]
Stock Based Compensation (Textual)
Stock option compensation expense													$ 190	$ 161
Employee Stock Option [Member] | Selling and Marketing Expense [Member]
Stock Based Compensation (Textual)
Stock option compensation expense													117	168
Employee Stock Option [Member] | General and Administrative [Member]
Stock Based Compensation (Textual)
Stock option compensation expense													$ 253	$ 211